{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:51:24Z","timestamp":1786974684257,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["22KK0279"],"award-info":[{"award-number":["22KK0279"]}]},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["JP18KK0454"],"award-info":[{"award-number":["JP18KK0454"]}]},{"name":"JSPS Core-to-Core Program","award":["JPJSCCB20240010"],"award-info":[{"award-number":["JPJSCCB20240010"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25wm0125003"],"award-info":[{"award-number":["JP25wm0125003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP19fm0208020"],"award-info":[{"award-number":["JP19fm0208020"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite global elimination targets set for 2030, Hepatitis B virus (HBV) infection remains a major public health challenge in low-income countries, including the Democratic Republic of Congo (DRC). Limited evidence on the regional transmission pathways precludes progress towards HBV elimination. This study aimed to assess the prevalence, molecular characteristics, and transmission dynamics of HBV in the Lukelenge health district, a peri-urban area in central DRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed a two-tiered recruitment strategy: community member volunteers were enrolled during the first phase, and upon notification of HBV positivity in an index case, family contacts were subsequently recruited in the second phase. Participants were screened for hepatitis B surface antigen (HBsAg), followed by PCR amplification of HBV DNA and sequencing. Genotyping and phylogenetic analysis of preS\/S sequences were performed to explore regional HBV diversity and transmission patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 751 participants from 677 households were included. The overall HBsAg prevalence was 3.8% [95% CI 2.6\u20135.7], with the highest rate (10.1% [95% CI 4.9\u201318.2]) found in children aged 5\u00a0years and younger. All 42 HBV isolates belonged to genotype E, with 97.6% sharing the\n                      <jats:italic>ayw4<\/jats:italic>\n                      serotype. Mutations with relevancy to immune escape were detected in 9.5% of strains, while those possibly linked to antiviral resistance were found in 4.7%. Maximum likelihood phylogenetic analysis showed intra-familial clustering of preS\/S sequences, suggesting that parent-to-child transmission was the most frequent mode of HBV spread in the study population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HBV in Lukelenge shows intermediate endemicity, especially affecting young children. Intra-familial transmission is revealed to be predominant, likely involving both vertical and horizontal pathways. Family-targeted interventions, including maternal screening and universal birth-dose vaccination, should be prioritized to eliminate HBV in this region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41182-025-00781-x","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T08:20:25Z","timestamp":1753690825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intra-familial transmission of Hepatitis B virus in a peri-urban community from the Democratic Republic of the Congo"],"prefix":"10.1186","volume":"53","author":[{"given":"Florence","family":"Cindibu Kalonji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Nakagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evariste","family":"Tshibangu-Kabamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kayiba Kalenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Nakagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachie","family":"Nakagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pathy","family":"Kamanga Nkolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Kalala-Tshituka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse","family":"Lufuluabu Mpemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustin","family":"Ndjibu Mpoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Kabongu Kalala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Muamba Mpoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9","family":"Mumba Ngoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shimakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislain","family":"Tumba Disashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"6","key":"781_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S2468-1253(24)00089-X","volume":"9","author":"PJ Easterbrook","year":"2024","unstructured":"Easterbrook PJ, Luhmann N, Bajis S, Min MS, Newman M, Lesi O, et al. WHO 2024 hepatitis B guidelines: an opportunity to transform care. Lancet Gastroenterol Hepatol. 2024;9(6):493\u20135.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"781_CR2","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021: towards ending viral hepatitis","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021: towards ending viral hepatitis. Geneva: WHO; 2016."},{"key":"781_CR3","volume-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: WHO; 2024."},{"issue":"1","key":"781_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/CLD.0000000000000166","volume":"23","author":"MW Sonderup","year":"2024","unstructured":"Sonderup MW, Spearman CW. HBV elimination in Africa\u2014Current status and challenges. Clin Liver Dis. 2024;23(1): e0166.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"781_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/v14010082","volume":"14","author":"MW Sonderup","year":"2022","unstructured":"Sonderup MW, Spearman CW. Global disparities in hepatitis B elimination\u2014a focus on Africa. Viruses. 2022;14(1):82.","journal-title":"Viruses"},{"issue":"1","key":"781_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4269\/ajtmh.18-0883","volume":"101","author":"P Thompson","year":"2019","unstructured":"Thompson P, Parr JB, Holzmayer V, Carrel M, Tshefu A, Mwandagalirwa K, et al. Seroepidemiology of hepatitis B in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2019;101(1):226.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"781_CR7","doi-asserted-by":"publisher","first-page":"e1600","DOI":"10.1016\/S2214-109X(21)00304-1","volume":"9","author":"P Thompson","year":"2021","unstructured":"Thompson P, Morgan CE, Ngimbi P, Mwandagalirwa K, Ravelomanana NLR, Tabala M, et al. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study. Lancet Glob Health. 2021;9(11):e1600\u20139.","journal-title":"Lancet Glob Health"},{"issue":"29","key":"781_CR8","first-page":"2016","volume":"72","author":"HJ Kabore","year":"2023","unstructured":"Kabore HJ, Li X, Alleman MM, Manzengo CM, Mumba M, Biey J, et al. Morbidity and mortality weekly report progress toward hepatitis b control and elimination of mother-to-child transmission of hepatitis B virus-World Health Organization African Region, 2016\u20132021. Centers Dis Control Prev. 2023;72(29):2016\u201321.","journal-title":"Centers Dis Control Prev"},{"issue":"6","key":"781_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12061207","volume":"12","author":"M Anderson","year":"2024","unstructured":"Anderson M, Mangogola T, Phinius BB, Mpebe G, Aimakhu CO, Choga WT, et al. Hepatitis B virus prevalence among HIV-uninfected people living in rural and peri-urban areas in Botswana. Microorganisms. 2024;12(6): 1207.","journal-title":"Microorganisms"},{"issue":"12","key":"781_CR10","first-page":"1","volume":"9","author":"CM Nlombi","year":"2019","unstructured":"Nlombi CM, Natuhoyila AN, Tudiakuilayi MM. Evaluation of seroprevalence and factors associated with the portage of HBsAg in pregnant women in rural Vanga and semi-urban Maluku. Int J Health Sci Res. 2019;9(12):1\u20139.","journal-title":"Int J Health Sci Res"},{"key":"781_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/cid\/ciab548","volume":"74","author":"J Moutchia","year":"2022","unstructured":"Moutchia J, Njouom R, Rumpler E, Besombes C, Texier G, Tejiokem M, et al. Maternal age at first childbirth and geographical variation in HBV prevalence in Cameroon: important role of mother-to-child transmission. Clin Infect Dis. 2022;74:836\u201345.","journal-title":"Clin Infect Dis"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/infdis\/161.6.1112","volume":"161","author":"H Whittle","year":"1990","unstructured":"Whittle H, Inskip H, Bradley AK, McLaughlan K, Shenton F, Lamb W, et al. The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis. 1990;161:1112\u20135. https:\/\/doi.org\/10.1093\/infdis\/161.6.1112.","journal-title":"J Infect Dis"},{"issue":"5","key":"781_CR13","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1016\/S2214-109X(23)00131-6","volume":"11","author":"A Ansari","year":"2023","unstructured":"Ansari A, Vincent JP, Moorhouse L, Shimakawa Y, Nayagam S. Risk of early horizontal transmission of hepatitis B virus in children of uninfected mothers in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2023;11(5):e715\u201328.","journal-title":"Lancet Glob Health"},{"key":"781_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofae150","volume":"11","author":"CE Morgan","year":"2024","unstructured":"Morgan CE, Ngimbi P, Boisson-Walsh AJN, Ntambua S, Matondo J, Tabala M, et al. Hepatitis B virus prevalence and transmission in the households of pregnant women in Kinshasa, Democratic Republic of Congo. Open Forum Infect Dis. 2024;11:1\u201310.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"781_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Cacciola I, Saffioti F, Raimondo G. Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications. J Hepatol. 2014;61(2):408\u201317. https:\/\/doi.org\/10.1016\/j.jhep.2014.04.041.","journal-title":"J Hepatol"},{"issue":"5","key":"781_CR16","first-page":"1","volume":"3","author":"CA Pinho-nascimento","year":"2018","unstructured":"Pinho-nascimento CA, Bratschi MW, Soares CC, Warryn L, Minyem JC, Terezinha M, et al. crossm transmission of hepatitis B and D viruses in an African rural. Am Soc Microbiol. 2018;3(5):1\u201315.","journal-title":"Am Soc Microbiol"},{"key":"781_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102180","author":"J Chen","year":"2023","unstructured":"Chen J, Li L, Yin Q, Shen T. A review of epidemiology and clinical relevance of Hepatitis B virus genotypes and subgenotypes. Clin Res Hepatol Gastroenterol. 2023. https:\/\/doi.org\/10.1016\/j.clinre.2023.102180.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"14","key":"781_CR18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3748\/wjg.v24.i14.1507","volume":"24","author":"BF Chen","year":"2018","unstructured":"Chen BF. Hepatitis B virus pre-S\/S variants in liver diseases. World J Gastroenterol. 2018;24(14):1507\u201320.","journal-title":"World J Gastroenterol"},{"key":"781_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tracli.2020.10.012","volume":"28","author":"AT Kabamba","year":"2021","unstructured":"Kabamba AT, Kalunga BT, Mwamba CM, Nyembo CM, Dufrasne F, Dessilly G, et al. Epidemiological aspects and molecular characterization of the hepatitis B virus among blood donors in Lubumbashi, Democratic Republic of Congo. Transfus Clin Biol. 2021;28:30\u20137.","journal-title":"Transfus Clin Biol"},{"key":"781_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.24837","volume":"90","author":"TA Shindano","year":"2018","unstructured":"Shindano TA, Horsmans Y, Kabamba BM. Genetic and phylogenic characterization of hepatitis B virus in the eastern part of the Democratic Republic of Congo. J Med Virol. 2018;90:250\u20134.","journal-title":"J Med Virol"},{"key":"781_CR21","unstructured":"Minist\u00e8re de la Sant\u00e9 Publique, R\u00e9publique D\u00e9mocratique du Congo. Enqu\u00eate nutritionnelle anthropom\u00e9trique et de mortalit\u00e9 selon la m\u00e9thodologie SMART. 2023:1\u20139."},{"key":"781_CR22","first-page":"25","volume":"3","author":"TS Nanjundeswaraswamy","year":"2021","unstructured":"Nanjundeswaraswamy TS, Divakar S. Determination of sample size and sampling methods in applied research. Proc Eng Sci. 2021;3:25\u201332.","journal-title":"Proc Eng Sci"},{"key":"781_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-4-1","volume":"4","author":"Q Zhang","year":"2007","unstructured":"Zhang Q, Wu G, Richards E, Jia S, Zeng C. Universal primers for HBV genome DNA amplification across subtypes: a case study for designing more effective viral primers. Virol J. 2007;4:1\u20137.","journal-title":"Virol J"},{"key":"781_CR24","unstructured":"Technelysium Pty Ltd. Chromas. Brisbane (Australia): Technelysium Pty Ltd; https:\/\/technelysium.com.au\/wp\/chromas\/"},{"key":"781_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30:772\u201380.","journal-title":"Mol Biol Evol"},{"key":"781_CR26","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, Von Haeseler A, et al. IQ-tree 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37:1530.","journal-title":"Mol Biol Evol"},{"key":"781_CR27","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","volume":"52","author":"I Letunic","year":"2024","unstructured":"Letunic I, Bork P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 2024;52:W78-82. https:\/\/doi.org\/10.1093\/nar\/gkae268.","journal-title":"Nucleic Acids Res"},{"key":"781_CR28","unstructured":"Genome Detective. Hepatitis B virus phylogenetic typing tool. https:\/\/www.genomedetective.com\/app\/typingtool\/hbv\/how-to-use"},{"key":"781_CR29","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38:3022\u20137. https:\/\/doi.org\/10.1093\/molbev\/msab120.","journal-title":"Mol Biol Evol"},{"key":"781_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/v7020781","volume":"7","author":"TG Bell","year":"2015","unstructured":"Bell TG, Kramvis A. Bioinformatics tools for small genomes, such as Hepatitis B virus. Viruses. 2015;7: 781.","journal-title":"Viruses"},{"key":"781_CR31","unstructured":"HIV-GRADE - HIV-GRADE viral Genotypic resistance algorithms. https:\/\/www.hiv-grade.de\/cms\/grade\/."},{"key":"781_CR32","unstructured":"The R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2024. https:\/\/www.R-project.org\/."},{"key":"781_CR33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355.","journal-title":"Lancet"},{"key":"781_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069430","volume":"8","author":"Y Shimakawa","year":"2013","unstructured":"Shimakawa Y, Yan HJ, Tsuchiya N, Bottomley C, Hall AJ. Association of early age at establishment of chronic Hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review. PLoS ONE. 2013;8: e69430.","journal-title":"PLoS ONE"},{"key":"781_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-12391-3","volume":"22","author":"S Moonsamy","year":"2022","unstructured":"Moonsamy S, Suchard M, Pillay P, Prabdial-Sing N. Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019. BMC Public Health. 2022;22:1\u201313. https:\/\/doi.org\/10.1186\/s12889-021-12391-3.","journal-title":"BMC Public Health"},{"key":"781_CR36","volume":"9","author":"MC Ezeilo","year":"2018","unstructured":"Ezeilo MC, Engwa GA, Iroha RI, Odimegwu DC. Seroprevalence and associated risk factors of hepatitis B virus infection among children in Enugu metropolis. Virol Res Treat. 2018;9: 0\u20136.","journal-title":"Virol Res Treat"},{"key":"781_CR37","volume-title":"Hepatitis B vaccination coverage: WHO\/UNICEF Estimates of National Immunization Coverage (WUENIC)","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Hepatitis B vaccination coverage: WHO\/UNICEF Estimates of National Immunization Coverage (WUENIC). Geneva: WHO; 2024."},{"key":"781_CR38","unstructured":"R\u00e9publique D\u00e9mocratique du Congo. Enqu\u00eate D\u00e9mographique et de Sant\u00e9 (EDS-RDC III) 2023\u20132024: rapport final. Kinshasa (RDC): Institut National de la Statistique, Ecole de Sant\u00e9 Publique de Kinshasa; 2025. 955 p."},{"key":"781_CR39","unstructured":"Organisation mondiale de la Sant\u00e9. Soutenir \u00ab le grand rattrapage \u00bb des enfants z\u00e9ro dose et sous-vaccin\u00e9s en R\u00e9publique d\u00e9mocratique du Congo. 2023 ao\u00fbt 10."},{"key":"781_CR40","unstructured":"Universit\u00e9 de Kinshasa, Ecole de Sant\u00e9 Publique. D\u00e9penses des m\u00e9nages pour la vaccination des enfants en R\u00e9publique D\u00e9mocratique du Congo : analyse du lien avec la couverture vaccinale des enfants de 6 \u00e0 23 mois. Note d\u2019information. Enqu\u00eate de couverture vaccinale ECV-RDC 2023\/04. Kinshasa (RDC) : Universit\u00e9 de Kinshasa; 2023."},{"key":"781_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-32865-1","volume":"13","author":"HM Kafeero","year":"2023","unstructured":"Kafeero HM, Ndagire D, Ocama P, Kato CD, Wampande E, Walusansa A, et al. Mapping hepatitis B virus genotypes on the African continent from 1997 to 2021: a systematic review with meta-analysis. Sci Rep. 2023;13:1\u201314. https:\/\/doi.org\/10.1038\/s41598-023-32865-1.","journal-title":"Sci Rep"},{"key":"781_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0168-8278(01)00064-2","volume":"35","author":"U Dumpis","year":"2001","unstructured":"Dumpis U, Holmes EC, Mendy M, Hill A, Thursz M, Hall A, et al. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol. 2001;35:99\u2013104.","journal-title":"J Hepatol"},{"key":"781_CR43","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.3748\/wjg.v20.i24.7653","volume":"20","author":"I Lazarevic","year":"2014","unstructured":"Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014;20:7653\u201364.","journal-title":"World J Gastroenterol"},{"key":"781_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/aob.2017.10.01","volume":"2","author":"J Wang","year":"2017","unstructured":"Wang J, Zhu B, Lu M, Yang D. Hepatitis B virus preS\/S gene mutations and their clinical implications. Ann Blood. 2017;2:17\u201317.","journal-title":"Ann Blood"},{"key":"781_CR45","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.12.24308840","author":"CE Morgan","year":"2024","unstructured":"Morgan CE, Powers KA, Edwards JK, et al. Characterizing hepatitis B virus infection in children in the Democratic Republic of Congo to inform elimination efforts. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.06.12.24308840.","journal-title":"medRxiv"},{"key":"781_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3748\/wjg.v22.i1.145","volume":"22","author":"P Caligiuri","year":"2016","unstructured":"Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol. 2016;22:145\u201354.","journal-title":"World J Gastroenterol"},{"key":"781_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4172\/1948-5964.1000156","volume":"09","author":"K Zhang","year":"2017","unstructured":"Zhang K, Bach C, Fraune MN, Xia Y, Beggel B, Kaiser R, et al. Novel rtM204 mutations in HBV polymerase confer reduced susceptibility to adefovir and tenofovir. J Antivirals Antiretrovirals. 2017;09:10\u20137.","journal-title":"J Antivirals Antiretrovirals"},{"key":"781_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1229-x","volume":"16","author":"H Desalegn","year":"2018","unstructured":"Desalegn H, Aberra H, Berhe N, Mekasha B, Stene-Johansen K, Krarup H, et al. Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia. BMC Med. 2018;16:1\u201310.","journal-title":"BMC Med"},{"key":"781_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101076","author":"SF Lumley","year":"2025","unstructured":"Lumley SF, Mokaya J, Maponga TG, Kramvis A, Dusheiko G, Irving W, et al. Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field. Lancet Microbe. 2025. https:\/\/doi.org\/10.1016\/j.lanmic.2025.101076.","journal-title":"Lancet Microbe"},{"key":"781_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.2.36","volume":"2","author":"CQ Pan","year":"2005","unstructured":"Pan CQ, Zhang JX. Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci. 2005;2:36\u201340.","journal-title":"Int J Med Sci"},{"key":"781_CR51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/oxfordjournals.aje.a009474","volume":"147","author":"FEA Martinson","year":"1998","unstructured":"Martinson FEA, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol. 1998;147:478\u201387.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"781_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/ID9.0000000000000128","volume":"4","author":"W Zhao","year":"2024","unstructured":"Zhao W. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection (text extract): executive summary. Infect Dis Immunity. 2024;4(3):103\u20135.","journal-title":"Infect Dis Immunity"},{"key":"781_CR53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2471\/BLT.21.287015","volume":"100","author":"AN Guingan\u00e9","year":"2022","unstructured":"Guingan\u00e9 AN, Kabor\u00e9 R, Shimakawa Y, Som\u00e9 EN, Kania D, Pisoni A, et al. Screening for hepatitis B in partners and children of women positive for surface antigen, Burkina Faso. Bull World Health Organ. 2022;100:256\u201367.","journal-title":"Bull World Health Organ"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00781-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00781-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T03:57:17Z","timestamp":1757303837000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00781-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00781-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6836597\/v1","asserted-by":"object"}]},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from adult participants and legal guardians for minors (under 18\u00a0years). Additionally, verbal assent was obtained from minors aged 15 to 18\u00a0years. The study followed the Declaration of Helsinki principles and was approved by the ethics committee of the University of Mbujimayi, the DRC (approval n#002\/CEI\/UM\/2023) and the Ethics Committee of Osaka Metropolitan University, Graduate School of Medicine, Japan (approval n#2025-047).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors have read and approved this manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}